Treatment of Hemophilia A Patients With FVIII Inhibitors

NCT04023019 · clinicaltrials.gov ↗

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Hemophilia A

Interventions

BIOLOGICAL: Nuwiq
BIOLOGICAL: Octanate
BIOLOGICAL: Wilate
BIOLOGICAL: Emicizumab
BIOLOGICAL: Recombinant factor VIIa (rFVIIa)
BIOLOGICAL: Activated prothrombin complex concentrate (aPCC)

Sponsor

Emory University

Collaborators

[object Object]